GENENTECH, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1976-01-01
- Employees
- 11.1K
- Market Cap
- -
- Website
- http://www.gene.com
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Genentech, Inc.
- Registration Number
- NCT00002004
- Locations
- 🇺🇸
Genentech Inc, South San Francisco, California, United States
A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Genentech, Inc.
- Registration Number
- NCT00002005
- Locations
- 🇺🇸
Genentech Inc, South San Francisco, California, United States
A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Genentech, Inc.
- Registration Number
- NCT00001992
- Locations
- 🇺🇸
Walter Reed Army Institute of Research, Rockville, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath